Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 101 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

11 trials in Phase 3/4

Results Transparency

5%

1 of 21 completed trials have results

Key Signals

22 recruiting1 with results

Enrollment Performance

Analytics

N/A
26(55.3%)
Phase 4
10(21.3%)
Phase 1
4(8.5%)
Phase 2
4(8.5%)
Early Phase 1
2(4.3%)
Phase 3
1(2.1%)
47Total
N/A(26)
Phase 4(10)
Phase 1(4)
Phase 2(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (101)

Showing 20 of 101 trials
NCT07575256Not ApplicableNot Yet Recruiting

Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures

Role: lead

NCT07560293Not Yet Recruiting

3D-EIT for Diagnosis and Monitoring of Pulmonary Embolism

Role: lead

NCT07538882Recruiting

AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma

Role: lead

NCT06783049Not ApplicableRecruiting

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Role: collaborator

NCT07336576Completed

Treatment Strategy for Adult Congenital Biliary Dilation

Role: lead

NCT07335042Recruiting

Prediction Model for MINS After Major Hepatobiliary Surgery

Role: lead

NCT07330271Not ApplicableRecruiting

PTC-Guided Therapy for Peritoneal Mesothelioma

Role: lead

NCT07328737Not ApplicableRecruiting

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Role: lead

NCT06839378Not ApplicableCompleted

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

Role: lead

NCT07152496Not Yet Recruiting

Host-Microbe Interactions in Biliary Dilatation

Role: lead

NCT07028164Completed

Clinical Features and Prognosis of Asymptomatic Biliary Dilatation

Role: lead

NCT07184424Not ApplicableCompleted

Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCC

Role: lead

NCT07123675Not ApplicableNot Yet Recruiting

AI-Assisted Blood Pressure Control During Anesthesia

Role: lead

NCT04532606Phase 4Recruiting

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Role: collaborator

NCT07088094Not ApplicableNot Yet Recruiting

The Clinical Study of Bone-patellar Tendon-bone and Quasi-anatomical Meniscus Allograft Transplantation Technique

Role: lead

NCT07036848Recruiting

Efficacy and Safety of Surgical Treatment for Type IVa CBD

Role: lead

NCT07070362Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Role: lead

NCT07058649Not Yet Recruiting

Downstaging Prediction Model for HCC

Role: lead

NCT07044947Not Yet Recruiting

Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC）

Role: lead

NCT07042841Enrolling By Invitation

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

Role: lead